Will be published at approximately 07:45 am CET.
Recipharm has convened a bondholder meeting to correct the terms and conditions of its convertible bonds and announces date for a preliminary 2020 year-end report
Announcement of consent solicitation by Recipharm AB (publ) in respect of its SEK 1,000,000,000 Senior Unsecured Convertible Bonds due 2021 (ISIN: XS1496895753)
See all financial press releases
Recipharm and Moderna finalize agreement for aseptic drug product manufacturing and fill-finish for supply to countries outside the U.S.